Ann: Kazia Half Year Accounts and Chairman's letter, page-86

Yes he did refer to it on at least one channel as being 'early glimpses'

Andi agree if you look at the MC it's well under valued James will agree too so does Edison's and you see the problem must be in the company - and I see it as external and a good opportunity as they are honest and honestly moving forward to be frank I don't think I've ever felt more integrity in any management team anywhere on any company large or small - they have won me with milestones.

Early glimpses is one phrase in one interview somewhere.... and the company have also said:

For the first time, we have concrete signals of clinical efficacy in the exact patient population that is targeted for commercialisation.

Put simply, on all available evidence, paxalisib works.

Time to get in Q you keep saying it's heading south it often looks like it could step down but doesn't - I think there are a growing population of firm hands mate and top 20 are increasing holdings so the pressure is at both ends - we are holding really well for a 'risky' biotech in a pretty aweful red day - these hands are not loose so we both know the pressure is building again...